271 related articles for article (PubMed ID: 22136209)
21. The impact of family history on non-medullary thyroid cancer.
Nixon IJ; Suárez C; Simo R; Sanabria A; Angelos P; Rinaldo A; Rodrigo JP; Kowalski LP; Hartl DM; Hinni ML; Shah JP; Ferlito A
Eur J Surg Oncol; 2016 Oct; 42(10):1455-63. PubMed ID: 27561845
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study.
Robenshtok E; Tzvetov G; Grozinsky-Glasberg S; Shraga-Slutzky I; Weinstein R; Lazar L; Serov S; Singer J; Hirsch D; Shimon I; Benbassat C
Thyroid; 2011 Jan; 21(1):43-8. PubMed ID: 20954815
[TBL] [Abstract][Full Text] [Related]
23. The familial counterparts of follicular cell--derived thyroid tumors.
Prazeres H; Torres J; Soares P; Sobrinho-Simões M
Int J Surg Pathol; 2010 Aug; 18(4):233-42. PubMed ID: 20444727
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and prognosis of familial follicular thyroid carcinoma.
Ito Y; Fukushima M; Yabuta T; Inoue H; Uruno T; Kihara M; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
Endocr J; 2008 Oct; 55(5):847-52. PubMed ID: 18506092
[TBL] [Abstract][Full Text] [Related]
25. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series.
Alsanea O; Wada N; Ain K; Wong M; Taylor K; Ituarte PH; Treseler PA; Weier HU; Freimer N; Siperstein AE; Duh QY; Takami H; Clark OH
Surgery; 2000 Dec; 128(6):1043-50;discussion 1050-1. PubMed ID: 11114641
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological features and prognosis of familial papillary thyroid carcinoma--a large-scale, matched, case-control study.
Cao J; Chen C; Chen C; Wang QL; Ge MH
Clin Endocrinol (Oxf); 2016 Apr; 84(4):598-606. PubMed ID: 26191611
[TBL] [Abstract][Full Text] [Related]
27. Allelic loss of susceptibility loci and the occurrence of BRAF and RAS mutations in patients with familial non-medullary thyroid cancer.
Na KY; Kim RM; Song EM; Lee JH; Lee J; Soh EY
J Surg Oncol; 2012 Jan; 105(1):10-4. PubMed ID: 21826673
[TBL] [Abstract][Full Text] [Related]
28. Detection of asymptomatic differentiated thyroid carcinoma by neck ultrasonographic screening for familial nonmedullary thyroid carcinoma.
Uchino S; Noguchi S; Yamashita H; Murakami T; Watanabe S; Ogawa T; Tsuno A; Shuto S
World J Surg; 2004 Nov; 28(11):1099-102. PubMed ID: 15490050
[TBL] [Abstract][Full Text] [Related]
29. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
30. An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up.
Sippel RS; Caron NR; Clark OH
World J Surg; 2007 May; 31(5):924-33. PubMed ID: 17429563
[TBL] [Abstract][Full Text] [Related]
31. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
[TBL] [Abstract][Full Text] [Related]
32. Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.
Burningham AR; Krishnan J; Davidson BJ; Ringel MD; Burman KD
Otolaryngol Head Neck Surg; 2005 Jun; 132(6):840-4. PubMed ID: 15944551
[TBL] [Abstract][Full Text] [Related]
33. Should Total Thyroidectomy Be Recommended for Patients with Familial Non-medullary Thyroid Cancer?
Kim YS; Seo M; Park SH; Ju SY; Kim ES
World J Surg; 2020 Sep; 44(9):3022-3027. PubMed ID: 32556933
[TBL] [Abstract][Full Text] [Related]
34. Biological behavior and prognosis of familial papillary thyroid carcinoma.
Ito Y; Kakudo K; Hirokawa M; Fukushima M; Yabuta T; Tomoda C; Inoue H; Kihara M; Higashiyama T; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
Surgery; 2009 Jan; 145(1):100-5. PubMed ID: 19081481
[TBL] [Abstract][Full Text] [Related]
35. Thyroid follicular carcinoma: sonographic features of 50 cases.
Sillery JC; Reading CC; Charboneau JW; Henrichsen TL; Hay ID; Mandrekar JN
AJR Am J Roentgenol; 2010 Jan; 194(1):44-54. PubMed ID: 20028904
[TBL] [Abstract][Full Text] [Related]
36. Endocrine tumours: familial nonmedullary thyroid carcinoma is a more aggressive disease: a systematic review and meta-analysis.
Wang X; Cheng W; Li J; Su A; Wei T; Liu F; Zhu J
Eur J Endocrinol; 2015 Jun; 172(6):R253-62. PubMed ID: 25637073
[TBL] [Abstract][Full Text] [Related]
37. Management of thyroid cancer of follicular cell origin: Gundersen/Lutheran Medical Center, 1969-1995.
Martins RG; Caplan RH; Lambert PJ; Rooney B; Kisken WA
J Am Coll Surg; 1997 Oct; 185(4):388-97. PubMed ID: 9328388
[TBL] [Abstract][Full Text] [Related]
38. Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients.
Capezzone M; Sagnella A; Cantara S; Fralassi N; Maino F; Forleo R; Brilli L; Pilli T; Cartocci A; Castagna MG
Front Endocrinol (Lausanne); 2022; 13():845954. PubMed ID: 35311228
[TBL] [Abstract][Full Text] [Related]
39. Does familial non-medullary thyroid cancer adversely affect survival?
Triponez F; Wong M; Sturgeon C; Caron N; Ginzinger DG; Segal MR; Kebebew E; Duh QY; Clark OH
World J Surg; 2006 May; 30(5):787-93. PubMed ID: 16479341
[TBL] [Abstract][Full Text] [Related]
40. Penetrance of a rare familial mutation predisposing to papillary thyroid cancer.
Saporito D; Brock P; Hampel H; Sipos J; Fernandez S; Liyanarachchi S; de la Chapelle A; Nagy R
Fam Cancer; 2018 Jul; 17(3):431-434. PubMed ID: 29027612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]